Fraction | UPLC Rt (min) | m/z of major [M + H]+ | Compound Mra | Theoretical Mrb | Mass error (ppm)c | Proposed compound identity |
---|---|---|---|---|---|---|
B | 4.27 | 407.2182 | 406.2104 | 406.2104 | 0.0 | Xenocoumacin 2 (C21H30N2O6) |
2.93 | 1052.7948 | 1051.7870 | 1051.7845 | 2.4 | PAX1’ (C14H27O2)GK6 | |
C | 3.18 | 1078.8119 | 1077.8041 | 1077.8001 | 3.7 | PAX7E1* (C16H29O2)GK6 |
3.42 | 1070.8091 | 1069.7921 | 1069.7951 | −2.8 | PAX1L* (C14H29O3)GK6 | |
D | 3.29 | 1066.8097 | 1065.7965 | 1065.8001 | −3.4 | PAX3’ (C15H29O2)GK6 |
F | 3.47 | 1054.8115 | 1053.8012 | 1053.8001 | 1.0 | PAX1L-DH* (C14H29O2)GK6 |
3.32, 3.47# | 1080.8286 | 1079.8191 | 1079.8158 | 3.1 | PAX7 (C16H31O2)GK6 | |
3.71 | 1078.8096 | 1077.8002 | 1077.8001 | 0.1 | PAX7E2* (C16H29O2)GK6 | |
3.88 | 1078.8070 | 1077.7979 | 1077.8001 | −2.0 | PAX7E3* (C16H29O2)GK6 | |
G | 2.51 | 1050.7723 | 1049.7623 | 1049.7688 | −6.2 | PAX5 (C14H25O2)GK6 |
 | 2.90 | 1052.7936 | 1051.7821 | 1051.7845 | 2.3 | PAX1’ (C14H27O2)GK6 |
 | 3.57 | 1080.8280 | 1079.8161 | 1079.8158 | 0.3 | PAX7 (C16H31O2)GK6 |
 | 3.83 | 1106.8412 | 1105.8294 | 1105.8314 | −1.8 | PAX8 (C18H33O2)GK6 |